Hormone medicines

Human chorionic gonadotropin (hCG)

An LH-like hormone with fertility indications; maintaining testicular testosterone is not the same as proving fertility.

Human endocrine and fertility research

Also known as: hCG

Practical use

Applying the explained evidence

Where it fits: An LH-like hormone with fertility indications; maintaining testicular testosterone is not the same as proving fertility.
Put the information into practice: The relevant outcomes form a chain: testicular hormone concentration, semen parameters, and pregnancy. Demonstrating one does not establish all three. Serum testosterone alone cannot answer whether sperm production is preserved.
Diagnosis before a number: Write down the symptoms, the reason a test was ordered, and the medicines already used. An isolated hormone result is a question to interpret, not a stand-alone reason to add another medicine.
Keep this limit in view: The randomized experiment measured testicular hormone concentration, not live birth or long-term semen outcomes.

Pregnyl prescribing information

Experimental intratesticular testosterone study

Overview

hCG activates the LH receptor and stimulates testicular steroid production. The urinary-derived Pregnyl product has labeled uses including selected male hypogonadotropic hypogonadism and female fertility treatment. It is not a general fertility guarantee or an approved weight-loss treatment.

Risks and limitations

The label identifies fluid retention and gynecomastia in men, hypersensitivity, and condition-specific contraindications. In ovarian stimulation, severe ovarian hyperstimulation and thromboembolic complications are separate major hazards. Male and female risks cannot be treated as identical.

How to read this

The relevant outcomes form a chain: testicular hormone concentration, semen parameters, and pregnancy. Demonstrating one does not establish all three. Serum testosterone alone cannot answer whether sperm production is preserved.

Research explained

Testicular testosterone under gonadotropin suppression

Who was studied

29 men with normal reproductive physiology; randomized, three-week experiment.

Intratesticular testosterone decrease: placebo arm: 94 %

What was found

With testosterone plus placebo, intratesticular testosterone fell 94%, from 1234 to 72 nmol/L. The hCG intervention arms showed a graded maintenance response.

What it cannot establish

Short duration and a surrogate hormone endpoint: this experiment did not establish pregnancy rates or long-term fertility preservation.

Read the original study

Semen findings during prescribed testosterone treatment

Who was studied

Retrospective records of 26 hypogonadal men; mean age 35.9 years and mean follow-up 6.2 months.

Participants: 26 men
Reported partner pregnancies: 9 pregnancies

What was found

No man became azoospermic during the combined clinical treatment, and 9 of 26 contributed to a partner pregnancy. Mean semen parameters did not significantly deteriorate.

What it cannot establish

Small, uncontrolled and selected population. Pregnancy also depends on partner factors, follow-up differed, and the study does not establish universal prevention.

Read the original study

Mechanism: an LH signal is not a full reproductive system

hCG provides LH-like stimulation. It does not recreate the complete pulsatile hypothalamic-pituitary system, and a testicular hormone response is not proof that every other requirement for spermatogenesis has recovered.

Supporting source

What the three-week experiment measured

Investigators sampled testicular fluid by fine-needle aspiration. This compartment contained far more testosterone than blood at baseline. A normal-looking blood testosterone result therefore cannot substitute for the study’s testicular measurement.

Supporting source

Formulation and timing limits

Urinary and recombinant products have their own labeling. This entry does not assign one universal half-life, interchangeability rule or recovery timeline across products and populations.

Supporting source

A fertility claim needs a fertility endpoint

The 26-man series is clinically relevant but has no randomized comparison. The observation of 9 pregnancies is not a 35% chance for a new individual and cannot isolate the drug’s effect from baseline fertility or partner factors.

Supporting source

What deserves prompt attention

Marked swelling, breathing difficulty or an allergic reaction needs medical attention. Medication and endocrine history matter before treatment; escalating hormone exposure to correct a single number is not a conclusion supported by these studies.

Supporting source

Claims versus findings

Not established

Maintained intratesticular testosterone proves fertility is preserved.

The randomized experiment measured testicular hormone concentration, not live birth or long-term semen outcomes.

Check the evidence

Common questions

Does this establish a guaranteed post-cycle recovery method?

No. These studies do not validate a universal recovery protocol after varied nonmedical drug exposure. The randomized study lasted only three weeks; the semen study was an uncontrolled clinical series.

Source